 | • レポートコード：MRC308GR11548 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界のリツキシマブ注射の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のリツキシマブ注射市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– リツキシマブ注射の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
リツキシマブ注射市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・先発医薬品、ジェネリック医薬品
用途別セグメント
・病院、診療所、その他
主要な市場プレーヤー
・Pfizer、Amgen、Roche、Celltrion、Innovent Biologics、Intas Pharmaceuticals、Shanghai Henlius Biotech、Fosun-Pharmaceutical、Lexicare Pharma、Healthiza Lifescience、Kavya Pharma、Cadila Pharmaceuticals、Dr Reddy’s Laboratories、Hetero Group、Probiomed、TRPharma、Zenotech Laboratories
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、リツキシマブ注射製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なリツキシマブ注射メーカーの企業概要、2019年～2022年までのリツキシマブ注射の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なリツキシマブ注射メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別リツキシマブ注射の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのリツキシマブ注射の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのリツキシマブ注射市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびリツキシマブ注射の産業チェーンを掲載しています。
・第14、15章では、リツキシマブ注射の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– リツキシマブ注射の概要
– 種類別分析（2018年vs2022年vs2029年）：先発医薬品、ジェネリック医薬品
– 用途別分析（2018年vs2022年vs2029年）：病院、診療所、その他
– 世界のリツキシマブ注射市場規模・予測
– 世界のリツキシマブ注射生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Pfizer、Amgen、Roche、Celltrion、Innovent Biologics、Intas Pharmaceuticals、Shanghai Henlius Biotech、Fosun-Pharmaceutical、Lexicare Pharma、Healthiza Lifescience、Kavya Pharma、Cadila Pharmaceuticals、Dr Reddy’s Laboratories、Hetero Group、Probiomed、TRPharma、Zenotech Laboratories
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：先発医薬品、ジェネリック医薬品
・用途別分析2018年-2029年：病院、診療所、その他
・リツキシマブ注射の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・リツキシマブ注射のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・リツキシマブ注射のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・リツキシマブ注射の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・リツキシマブ注射の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Rituximab Injection
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Rituximab Injection Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Original Drugs
1.3.3 Generic Drugs
1.4 Market Analysis by Application
1.4.1 Overview: Global Rituximab Injection Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Others
1.5 Global Rituximab Injection Market Size & Forecast
1.5.1 Global Rituximab Injection Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Rituximab Injection Sales Quantity (2018-2029)
1.5.3 Global Rituximab Injection Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Rituximab Injection Product and Services
2.1.4 Pfizer Rituximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Recent Developments/Updates
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Rituximab Injection Product and Services
2.2.4 Amgen Rituximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Amgen Recent Developments/Updates
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Rituximab Injection Product and Services
2.3.4 Roche Rituximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Roche Recent Developments/Updates
2.4 Celltrion
2.4.1 Celltrion Details
2.4.2 Celltrion Major Business
2.4.3 Celltrion Rituximab Injection Product and Services
2.4.4 Celltrion Rituximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Celltrion Recent Developments/Updates
2.5 Innovent Biologics
2.5.1 Innovent Biologics Details
2.5.2 Innovent Biologics Major Business
2.5.3 Innovent Biologics Rituximab Injection Product and Services
2.5.4 Innovent Biologics Rituximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Innovent Biologics Recent Developments/Updates
2.6 Intas Pharmaceuticals
2.6.1 Intas Pharmaceuticals Details
2.6.2 Intas Pharmaceuticals Major Business
2.6.3 Intas Pharmaceuticals Rituximab Injection Product and Services
2.6.4 Intas Pharmaceuticals Rituximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Intas Pharmaceuticals Recent Developments/Updates
2.7 Shanghai Henlius Biotech
2.7.1 Shanghai Henlius Biotech Details
2.7.2 Shanghai Henlius Biotech Major Business
2.7.3 Shanghai Henlius Biotech Rituximab Injection Product and Services
2.7.4 Shanghai Henlius Biotech Rituximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Shanghai Henlius Biotech Recent Developments/Updates
2.8 Fosun-Pharmaceutical
2.8.1 Fosun-Pharmaceutical Details
2.8.2 Fosun-Pharmaceutical Major Business
2.8.3 Fosun-Pharmaceutical Rituximab Injection Product and Services
2.8.4 Fosun-Pharmaceutical Rituximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Fosun-Pharmaceutical Recent Developments/Updates
2.9 Lexicare Pharma
2.9.1 Lexicare Pharma Details
2.9.2 Lexicare Pharma Major Business
2.9.3 Lexicare Pharma Rituximab Injection Product and Services
2.9.4 Lexicare Pharma Rituximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Lexicare Pharma Recent Developments/Updates
2.10 Healthiza Lifescience
2.10.1 Healthiza Lifescience Details
2.10.2 Healthiza Lifescience Major Business
2.10.3 Healthiza Lifescience Rituximab Injection Product and Services
2.10.4 Healthiza Lifescience Rituximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Healthiza Lifescience Recent Developments/Updates
2.11 Kavya Pharma
2.11.1 Kavya Pharma Details
2.11.2 Kavya Pharma Major Business
2.11.3 Kavya Pharma Rituximab Injection Product and Services
2.11.4 Kavya Pharma Rituximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Kavya Pharma Recent Developments/Updates
2.12 Cadila Pharmaceuticals
2.12.1 Cadila Pharmaceuticals Details
2.12.2 Cadila Pharmaceuticals Major Business
2.12.3 Cadila Pharmaceuticals Rituximab Injection Product and Services
2.12.4 Cadila Pharmaceuticals Rituximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Cadila Pharmaceuticals Recent Developments/Updates
2.13 Dr Reddy’s Laboratories
2.13.1 Dr Reddy’s Laboratories Details
2.13.2 Dr Reddy’s Laboratories Major Business
2.13.3 Dr Reddy’s Laboratories Rituximab Injection Product and Services
2.13.4 Dr Reddy’s Laboratories Rituximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Dr Reddy’s Laboratories Recent Developments/Updates
2.14 Hetero Group
2.14.1 Hetero Group Details
2.14.2 Hetero Group Major Business
2.14.3 Hetero Group Rituximab Injection Product and Services
2.14.4 Hetero Group Rituximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Hetero Group Recent Developments/Updates
2.15 Probiomed
2.15.1 Probiomed Details
2.15.2 Probiomed Major Business
2.15.3 Probiomed Rituximab Injection Product and Services
2.15.4 Probiomed Rituximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Probiomed Recent Developments/Updates
2.16 TRPharma
2.16.1 TRPharma Details
2.16.2 TRPharma Major Business
2.16.3 TRPharma Rituximab Injection Product and Services
2.16.4 TRPharma Rituximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 TRPharma Recent Developments/Updates
2.17 Zenotech Laboratories
2.17.1 Zenotech Laboratories Details
2.17.2 Zenotech Laboratories Major Business
2.17.3 Zenotech Laboratories Rituximab Injection Product and Services
2.17.4 Zenotech Laboratories Rituximab Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Zenotech Laboratories Recent Developments/Updates
3 Competitive Environment: Rituximab Injection by Manufacturer
3.1 Global Rituximab Injection Sales Quantity by Manufacturer (2018-2023)
3.2 Global Rituximab Injection Revenue by Manufacturer (2018-2023)
3.3 Global Rituximab Injection Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Rituximab Injection by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Rituximab Injection Manufacturer Market Share in 2022
3.4.2 Top 6 Rituximab Injection Manufacturer Market Share in 2022
3.5 Rituximab Injection Market: Overall Company Footprint Analysis
3.5.1 Rituximab Injection Market: Region Footprint
3.5.2 Rituximab Injection Market: Company Product Type Footprint
3.5.3 Rituximab Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Rituximab Injection Market Size by Region
4.1.1 Global Rituximab Injection Sales Quantity by Region (2018-2029)
4.1.2 Global Rituximab Injection Consumption Value by Region (2018-2029)
4.1.3 Global Rituximab Injection Average Price by Region (2018-2029)
4.2 North America Rituximab Injection Consumption Value (2018-2029)
4.3 Europe Rituximab Injection Consumption Value (2018-2029)
4.4 Asia-Pacific Rituximab Injection Consumption Value (2018-2029)
4.5 South America Rituximab Injection Consumption Value (2018-2029)
4.6 Middle East and Africa Rituximab Injection Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Rituximab Injection Sales Quantity by Type (2018-2029)
5.2 Global Rituximab Injection Consumption Value by Type (2018-2029)
5.3 Global Rituximab Injection Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Rituximab Injection Sales Quantity by Application (2018-2029)
6.2 Global Rituximab Injection Consumption Value by Application (2018-2029)
6.3 Global Rituximab Injection Average Price by Application (2018-2029)
7 North America
7.1 North America Rituximab Injection Sales Quantity by Type (2018-2029)
7.2 North America Rituximab Injection Sales Quantity by Application (2018-2029)
7.3 North America Rituximab Injection Market Size by Country
7.3.1 North America Rituximab Injection Sales Quantity by Country (2018-2029)
7.3.2 North America Rituximab Injection Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Rituximab Injection Sales Quantity by Type (2018-2029)
8.2 Europe Rituximab Injection Sales Quantity by Application (2018-2029)
8.3 Europe Rituximab Injection Market Size by Country
8.3.1 Europe Rituximab Injection Sales Quantity by Country (2018-2029)
8.3.2 Europe Rituximab Injection Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Rituximab Injection Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Rituximab Injection Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Rituximab Injection Market Size by Region
9.3.1 Asia-Pacific Rituximab Injection Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Rituximab Injection Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Rituximab Injection Sales Quantity by Type (2018-2029)
10.2 South America Rituximab Injection Sales Quantity by Application (2018-2029)
10.3 South America Rituximab Injection Market Size by Country
10.3.1 South America Rituximab Injection Sales Quantity by Country (2018-2029)
10.3.2 South America Rituximab Injection Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Rituximab Injection Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Rituximab Injection Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Rituximab Injection Market Size by Country
11.3.1 Middle East & Africa Rituximab Injection Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Rituximab Injection Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Rituximab Injection Market Drivers
12.2 Rituximab Injection Market Restraints
12.3 Rituximab Injection Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Rituximab Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Rituximab Injection
13.3 Rituximab Injection Production Process
13.4 Rituximab Injection Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Rituximab Injection Typical Distributors
14.3 Rituximab Injection Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Rituximab Injection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Rituximab Injection Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Rituximab Injection Product and Services
Table 6. Pfizer Rituximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Pfizer Recent Developments/Updates
Table 8. Amgen Basic Information, Manufacturing Base and Competitors
Table 9. Amgen Major Business
Table 10. Amgen Rituximab Injection Product and Services
Table 11. Amgen Rituximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Amgen Recent Developments/Updates
Table 13. Roche Basic Information, Manufacturing Base and Competitors
Table 14. Roche Major Business
Table 15. Roche Rituximab Injection Product and Services
Table 16. Roche Rituximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Roche Recent Developments/Updates
Table 18. Celltrion Basic Information, Manufacturing Base and Competitors
Table 19. Celltrion Major Business
Table 20. Celltrion Rituximab Injection Product and Services
Table 21. Celltrion Rituximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Celltrion Recent Developments/Updates
Table 23. Innovent Biologics Basic Information, Manufacturing Base and Competitors
Table 24. Innovent Biologics Major Business
Table 25. Innovent Biologics Rituximab Injection Product and Services
Table 26. Innovent Biologics Rituximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Innovent Biologics Recent Developments/Updates
Table 28. Intas Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 29. Intas Pharmaceuticals Major Business
Table 30. Intas Pharmaceuticals Rituximab Injection Product and Services
Table 31. Intas Pharmaceuticals Rituximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Intas Pharmaceuticals Recent Developments/Updates
Table 33. Shanghai Henlius Biotech Basic Information, Manufacturing Base and Competitors
Table 34. Shanghai Henlius Biotech Major Business
Table 35. Shanghai Henlius Biotech Rituximab Injection Product and Services
Table 36. Shanghai Henlius Biotech Rituximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Shanghai Henlius Biotech Recent Developments/Updates
Table 38. Fosun-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Fosun-Pharmaceutical Major Business
Table 40. Fosun-Pharmaceutical Rituximab Injection Product and Services
Table 41. Fosun-Pharmaceutical Rituximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Fosun-Pharmaceutical Recent Developments/Updates
Table 43. Lexicare Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Lexicare Pharma Major Business
Table 45. Lexicare Pharma Rituximab Injection Product and Services
Table 46. Lexicare Pharma Rituximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Lexicare Pharma Recent Developments/Updates
Table 48. Healthiza Lifescience Basic Information, Manufacturing Base and Competitors
Table 49. Healthiza Lifescience Major Business
Table 50. Healthiza Lifescience Rituximab Injection Product and Services
Table 51. Healthiza Lifescience Rituximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Healthiza Lifescience Recent Developments/Updates
Table 53. Kavya Pharma Basic Information, Manufacturing Base and Competitors
Table 54. Kavya Pharma Major Business
Table 55. Kavya Pharma Rituximab Injection Product and Services
Table 56. Kavya Pharma Rituximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Kavya Pharma Recent Developments/Updates
Table 58. Cadila Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 59. Cadila Pharmaceuticals Major Business
Table 60. Cadila Pharmaceuticals Rituximab Injection Product and Services
Table 61. Cadila Pharmaceuticals Rituximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Cadila Pharmaceuticals Recent Developments/Updates
Table 63. Dr Reddy’s Laboratories Basic Information, Manufacturing Base and Competitors
Table 64. Dr Reddy’s Laboratories Major Business
Table 65. Dr Reddy’s Laboratories Rituximab Injection Product and Services
Table 66. Dr Reddy’s Laboratories Rituximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Dr Reddy’s Laboratories Recent Developments/Updates
Table 68. Hetero Group Basic Information, Manufacturing Base and Competitors
Table 69. Hetero Group Major Business
Table 70. Hetero Group Rituximab Injection Product and Services
Table 71. Hetero Group Rituximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Hetero Group Recent Developments/Updates
Table 73. Probiomed Basic Information, Manufacturing Base and Competitors
Table 74. Probiomed Major Business
Table 75. Probiomed Rituximab Injection Product and Services
Table 76. Probiomed Rituximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Probiomed Recent Developments/Updates
Table 78. TRPharma Basic Information, Manufacturing Base and Competitors
Table 79. TRPharma Major Business
Table 80. TRPharma Rituximab Injection Product and Services
Table 81. TRPharma Rituximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. TRPharma Recent Developments/Updates
Table 83. Zenotech Laboratories Basic Information, Manufacturing Base and Competitors
Table 84. Zenotech Laboratories Major Business
Table 85. Zenotech Laboratories Rituximab Injection Product and Services
Table 86. Zenotech Laboratories Rituximab Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Zenotech Laboratories Recent Developments/Updates
Table 88. Global Rituximab Injection Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 89. Global Rituximab Injection Revenue by Manufacturer (2018-2023) & (USD Million)
Table 90. Global Rituximab Injection Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 91. Market Position of Manufacturers in Rituximab Injection, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 92. Head Office and Rituximab Injection Production Site of Key Manufacturer
Table 93. Rituximab Injection Market: Company Product Type Footprint
Table 94. Rituximab Injection Market: Company Product Application Footprint
Table 95. Rituximab Injection New Market Entrants and Barriers to Market Entry
Table 96. Rituximab Injection Mergers, Acquisition, Agreements, and Collaborations
Table 97. Global Rituximab Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 98. Global Rituximab Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 99. Global Rituximab Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 100. Global Rituximab Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 101. Global Rituximab Injection Average Price by Region (2018-2023) & (US$/Unit)
Table 102. Global Rituximab Injection Average Price by Region (2024-2029) & (US$/Unit)
Table 103. Global Rituximab Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 104. Global Rituximab Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 105. Global Rituximab Injection Consumption Value by Type (2018-2023) & (USD Million)
Table 106. Global Rituximab Injection Consumption Value by Type (2024-2029) & (USD Million)
Table 107. Global Rituximab Injection Average Price by Type (2018-2023) & (US$/Unit)
Table 108. Global Rituximab Injection Average Price by Type (2024-2029) & (US$/Unit)
Table 109. Global Rituximab Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 110. Global Rituximab Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 111. Global Rituximab Injection Consumption Value by Application (2018-2023) & (USD Million)
Table 112. Global Rituximab Injection Consumption Value by Application (2024-2029) & (USD Million)
Table 113. Global Rituximab Injection Average Price by Application (2018-2023) & (US$/Unit)
Table 114. Global Rituximab Injection Average Price by Application (2024-2029) & (US$/Unit)
Table 115. North America Rituximab Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 116. North America Rituximab Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 117. North America Rituximab Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 118. North America Rituximab Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 119. North America Rituximab Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 120. North America Rituximab Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 121. North America Rituximab Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 122. North America Rituximab Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 123. Europe Rituximab Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 124. Europe Rituximab Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 125. Europe Rituximab Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 126. Europe Rituximab Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 127. Europe Rituximab Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 128. Europe Rituximab Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 129. Europe Rituximab Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 130. Europe Rituximab Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 131. Asia-Pacific Rituximab Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 132. Asia-Pacific Rituximab Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 133. Asia-Pacific Rituximab Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 134. Asia-Pacific Rituximab Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 135. Asia-Pacific Rituximab Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 136. Asia-Pacific Rituximab Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 137. Asia-Pacific Rituximab Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 138. Asia-Pacific Rituximab Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 139. South America Rituximab Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 140. South America Rituximab Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 141. South America Rituximab Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 142. South America Rituximab Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 143. South America Rituximab Injection Sales Quantity by Country (2018-2023) & (K Units)
Table 144. South America Rituximab Injection Sales Quantity by Country (2024-2029) & (K Units)
Table 145. South America Rituximab Injection Consumption Value by Country (2018-2023) & (USD Million)
Table 146. South America Rituximab Injection Consumption Value by Country (2024-2029) & (USD Million)
Table 147. Middle East & Africa Rituximab Injection Sales Quantity by Type (2018-2023) & (K Units)
Table 148. Middle East & Africa Rituximab Injection Sales Quantity by Type (2024-2029) & (K Units)
Table 149. Middle East & Africa Rituximab Injection Sales Quantity by Application (2018-2023) & (K Units)
Table 150. Middle East & Africa Rituximab Injection Sales Quantity by Application (2024-2029) & (K Units)
Table 151. Middle East & Africa Rituximab Injection Sales Quantity by Region (2018-2023) & (K Units)
Table 152. Middle East & Africa Rituximab Injection Sales Quantity by Region (2024-2029) & (K Units)
Table 153. Middle East & Africa Rituximab Injection Consumption Value by Region (2018-2023) & (USD Million)
Table 154. Middle East & Africa Rituximab Injection Consumption Value by Region (2024-2029) & (USD Million)
Table 155. Rituximab Injection Raw Material
Table 156. Key Manufacturers of Rituximab Injection Raw Materials
Table 157. Rituximab Injection Typical Distributors
Table 158. Rituximab Injection Typical Customers
List of Figures
Figure 1. Rituximab Injection Picture
Figure 2. Global Rituximab Injection Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Rituximab Injection Consumption Value Market Share by Type in 2022
Figure 4. Original Drugs Examples
Figure 5. Generic Drugs Examples
Figure 6. Global Rituximab Injection Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Rituximab Injection Consumption Value Market Share by Application in 2022
Figure 8. Hospitals Examples
Figure 9. Clinics Examples
Figure 10. Others Examples
Figure 11. Global Rituximab Injection Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Rituximab Injection Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Rituximab Injection Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Rituximab Injection Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Rituximab Injection Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Rituximab Injection Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Rituximab Injection by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Rituximab Injection Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Rituximab Injection Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Rituximab Injection Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Rituximab Injection Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Rituximab Injection Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Rituximab Injection Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Rituximab Injection Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Rituximab Injection Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Rituximab Injection Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Rituximab Injection Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Rituximab Injection Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Rituximab Injection Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Rituximab Injection Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Rituximab Injection Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Rituximab Injection Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Rituximab Injection Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Rituximab Injection Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Rituximab Injection Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Rituximab Injection Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Rituximab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Rituximab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Rituximab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Rituximab Injection Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Rituximab Injection Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Rituximab Injection Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Rituximab Injection Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Rituximab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Rituximab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Rituximab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Rituximab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Rituximab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Rituximab Injection Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Rituximab Injection Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Rituximab Injection Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Rituximab Injection Consumption Value Market Share by Region (2018-2029)
Figure 53. China Rituximab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Rituximab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Rituximab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Rituximab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Rituximab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Rituximab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Rituximab Injection Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Rituximab Injection Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Rituximab Injection Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Rituximab Injection Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Rituximab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Rituximab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Rituximab Injection Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Rituximab Injection Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Rituximab Injection Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Rituximab Injection Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Rituximab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Rituximab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Rituximab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Rituximab Injection Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Rituximab Injection Market Drivers
Figure 74. Rituximab Injection Market Restraints
Figure 75. Rituximab Injection Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Rituximab Injection in 2022
Figure 78. Manufacturing Process Analysis of Rituximab Injection
Figure 79. Rituximab Injection Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source